TruBridge (TBRG) AI Stock Analysis

• Market Cap: $292.58M
• Dividend Yield: N/A
• Average Volume (3M): 110.38K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.54
• Revenue Growth: 3.42%
• EPS Growth: 77.05%
• Country: US
• Employees: 3,200
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 0.54
• Shares Outstanding: 15,011,642
• 10 Day Avg. Volume: 98,314
• 30 Day Avg. Volume: 110,375
• PEG Ratio: 0.25
• Price to Book (P/B): 1.67
• Price to Sales (P/S): 0.82
• P/FCF Ratio: 21.63
• Enterprise Value/Market Cap: 1.70
• Enterprise Value/Revenue: 1.43
• Enterprise Value/Gross Profit: 2.49
• Enterprise Value/Ebitda: 10.52
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 61 Neutral
• Price Target: $21.00 ▲(7.58% Upside)

TruBridge's overall stock score is driven by strong revenue growth and strategic collaborations, such as with Microsoft. However, profitability challenges, weak technical indicators, and valuation concerns weigh on the score. The earnings call provided some optimism with improved bookings and profitability, but revenue and client retention issues remain significant risks.

TruBridge Business Overview & Revenue Model

Company Description

TruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence. The company provides acute care solutions and related services for community hospitals, and physician clinics; and patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. In addition, it offers patient liability estimates eligibility verification, claim scrubbing and submission, remittance management, denial/audit management, and contract management; and offers RCM services, such as accounts receivable management, private pay service, medical coding, revenue cycle consulting, and other additional insurance and patient billing services. Further, it offers consulting and business management services; managed IT services; encoder solutions; patient management; financial accounting; clinical; patient care; and enterprise applications. Additionally, it offers TruBridge HER platform, including total system support, national client conference, continuing education, software releases, hardware replacement, cloud electronic health record, forms and supplies, and public cloud infrastructure services; post-acute care software systems, and support and maintenance services; and InstantPHR, an interactive portal and CHBase which funnels data from multiple sources into one platform. The company was formerly known as Computer Programs and Systems, Inc. and changed its name to TruBridge, Inc. in March 2024. TruBridge, Inc. was founded in 1979 and is headquartered in Mobile, Alabama.

How the Company Makes Money

TruBridge generates revenue primarily through its services in revenue cycle management and healthcare consulting. Key revenue streams include fees charged for software subscriptions, consulting services, and performance-based contracts with healthcare providers. The company also benefits from partnerships with technology providers and healthcare organizations, which can enhance its service offerings and expand its client base. Additionally, TBRG may earn revenue through training and support services for its clients, further solidifying its presence in the healthcare market.

TruBridge Financial Statement Overview

Summary

TruBridge demonstrates solid revenue growth and a strong balance sheet with low leverage, indicating financial stability. However, persistent net losses highlight profitability challenges. Cash flows remain strong, supporting operational needs, but improving profitability is crucial for enhancing financial health.

Income Statement

TruBridge's TTM (Trailing-Twelve-Months) revenue shows modest growth, but net income remains negative, impacting net profit margins adversely. Gross profit margin is healthy at approximately 49.3%, indicating efficient cost management. However, negative net profit margins and fluctuating EBIT margins suggest challenges in profitability and operational efficiency.

Balance Sheet

The company's balance sheet reflects a strong equity position with an equity ratio of 43.3%. The debt-to-equity ratio is low at approximately 0.03, indicating low leverage and reduced financial risk. Despite this, a decline in total assets over time suggests potential concerns in asset management or reinvestment strategies.

Cash Flow

TruBridge's TTM (Trailing-Twelve-Months) operating cash flow is robust, leading to a favorable operating cash flow to net income ratio. Free cash flow has shown growth, but the free cash flow to net income ratio highlights issues due to negative net income figures. Overall, cash flow management appears strong despite profitability challenges.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	347.61M	342.65M	339.44M	326.65M	280.63M	264.49M
Gross Profit	199.17M	174.12M	163.57M	160.11M	144.85M	136.25M
EBITDA	47.21M	34.94M	-15.39M	47.73M	43.11M	35.56M
Net Income	-12.35M	-20.44M	-45.79M	15.87M	18.43M	14.25M
Balance Sheet
Total Assets	390.15M	394.43M	434.42M	430.96M	383.35M	326.27M
Cash, Cash Equivalents and Short-Term Investments	12.28M	12.32M	3.85M	6.95M	11.43M	12.67M
Total Debt	4.81M	174.81M	203.29M	147.24M	106.46M	83.43M
Total Liabilities	216.98M	225.74M	247.80M	199.25M	160.78M	126.27M
Stockholders Equity	173.17M	168.69M	186.62M	231.71M	222.57M	200.00M
Cash Flow
Free Cash Flow	20.57M	13.04M	-22.35M	13.01M	37.46M	42.48M
Operating Cash Flow	34.92M	32.13M	1.06M	32.38M	47.74M	49.14M
Investing Cash Flow	-13.95M	4.12M	-60.11M	-62.73M	-69.92M	-6.66M
Financing Cash Flow	-16.40M	-27.74M	55.95M	25.88M	20.93M	-37.16M

TruBridge Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 19.52
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TBRG, the sentiment is Negative. The current price of 19.52 is below the 20-day moving average (MA) of 19.90, below the 50-day MA of 20.20, and below the 200-day MA of 23.51, indicating a bearish trend. The MACD of -0.25 indicates Positive momentum. The RSI at 42.22 is Neutral, neither overbought nor oversold. The STOCH value of 35.38 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TBRG.

TruBridge Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SPOK	―	$325.54M	19.86	11.03%	7.62%	1.79%	8.48%
OPRX	―	$402.49M	―	-8.21%	―	25.90%	46.13%
SLP	―	$358.06M	-5.66	-41.49%	0.33%	20.01%	-750.59%
NRC	―	$310.20M	18.81	66.53%	3.62%	-3.50%	-36.95%
TBRG	―	$292.58M	-23.09	-6.81%	―	3.42%	77.05%
HCAT	―	$237.86M	―	-28.42%	―	5.55%	-0.99%
Sector *	―	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

TruBridge Corporate Events

TruBridge Appoints New Chief Business Officer

On October 1, 2025, TruBridge announced that Dawn M. Severance would step down as Chief Sales Officer by October 31, 2025, following the company’s decision to eliminate the position. Her departure is amicable and not due to any disagreements, and she will receive severance benefits as per her agreement. On October 3, 2025, TruBridge appointed Michael Daughton as Chief Business Officer, effective October 6, 2025, to enhance client-centered excellence and growth. Daughton, with 30 years of strategic healthcare leadership experience, is expected to drive shareholder value and reinforce TruBridge’s commitment to rural and community healthcare.

The most recent analyst rating on (TBRG) stock is a Hold with a $22.50 price target. To see the full list of analyst forecasts on TruBridge stock, see the TBRG Stock Forecast page.

Trubridge, Inc. Earnings Call: Cautious Optimism Amid Challenges

The recent earnings call for Trubridge, Inc. painted a picture of cautious optimism. While the company celebrated several positive developments such as improved booking performance, enhanced cash flow, and strategic partnerships, it also acknowledged challenges with revenue guidance, client retention, and operational delays. This balanced view suggests that while there are hurdles to overcome, strategic improvements are underway.

TruBridge, Inc. Reports Steady Q2 2025 Performance

TruBridge, Inc. is a healthcare solutions company that provides technology, services, and strategic expertise to support rural and community hospitals in the United States. With over 45 years of experience, the company focuses on revenue cycle management, electronic health records, and analytics to help healthcare providers remain independent and community-focused.